ACST-1 Long Term Follow-up

ACST-2 is supported by:

ACST-1 Long Term Follow-up

 

ACST-1 (ISRCTN26156392) is an international randomised trial. The aim of this trial is to find out whether carotid endarterectomy (CEA) and best medical treatment (BMT) together improve stroke-free survival time when compared to BMT alone. The study also aims to identify high-risk groups for whom the benefits of surgery and of BMT are increased. The long-term follow-up is looking at whether carotid endarterectomy reduces the risk of dementia.

 

Carotid stenosis is a condition where one or both of the carotid arteries (the main blood vessels that supply the head and neck) become narrowed due to a build-up of fatty deposits (plaque). This increases the risk of having a stroke, when the blood supply to part of the brain is cut off

 

Between 1993 and 2008 ASCT-1 included 3120 patients and is now looking at whether carotid endarterectomy reduces the risk of dementia. To find out more about this long term follow up please see:

 

ACST-1 Long-term follow-up protocol v6.2

 

ACST-1 Long-term follow-up overview and contact v1.0

 

Copyright © 2011-2017 Nuffield Department of Surgical Sciences, John Radcliffe Hospital, Headington, Oxford, OX3 9DU

 

About Cookies Freedom of Information Privacy Policy University Copyright Statement University Accessibility Statement

Follow ACST-2

@NDSurgicalSci